药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02269 药明生物

休市中 05-25 16:08:15

42.950

-1.400

-3.16%

最高43.950	最低42.550	成交量1,299万
今开43.750	昨收44.350	日振幅3.16%
总市值1,817亿	流通市值1,817亿	总股本42.30亿
成交额5.60亿	换手率0.31%	流通股本42.30亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"药明生物","latestPrice":42.95,"timestamp":1685002095016,"preClose":44.35,"halted":0,"volume":12986011,"delay":0,"floatShares":4229779102,"shares":4229779102,"eps":1.1733952,"marketStatus":"休市中","marketStatusCode":7,"change":-1.4,"latestTime":"05-25 16:08:15","open":43.75,"high":43.95,"low":42.55,"amount":559831853,"amplitude":0.031567,"askPrice":43,"askSize":174000,"bidPrice":42.95,"bidSize":162500,"shortable":3,"etf":0,"ttmEps":1.118758763306518,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1685323800000},"adr":0,"listingDate":1497283200000,"adjPreClose":44.35,"adrRate":0,"volumeRatio":0.7647141993479043,"optionData":{"bulkOrders":[{"symbol":"WXB.HK","call":true,"expireDate":1687968000000,"strike":"50.00","timestamp":1684983091755,"price":0.7200000286102295,"volume":216,"amount":77760,"type":"*"},{"symbol":"WXB.HK","call":false,"expireDate":1685376000000,"strike":"45.00","timestamp":1684995379865,"price":2.2799999713897705,"volume":203,"amount":231420,"type":"-"}]},"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK"},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"2337968823","title":"睿智医药(300149.SZ)：Lonza、三星、药明生物等大型公司仍然保持占主导地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2337968823","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2337968823?lang=zh_CN&edition=full","pubTime":"2023-05-23 20:55","pubTimestamp":1684846544,"startTime":"0","endTime":"0","summary":"来源：格隆汇格隆汇5月23日丨睿智医药(300149.SZ)在5月23日15:00-17:00业绩说明会表示，国际竞争格局为Lonza、三星、药明生物等大型公司仍然保持占主导地位，国内市场竞争激烈。公司的大分子CDMO业务也将继续按照“跟随分子”战略，紧盯热点分子如ADC领域，更好的为客户服务，并争取获取更多的订单。\n\n炒股开户享福利，送投顾服务60天体验权，一对一指导服务！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-05-23/doc-imyuupnw7022109.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-05-23/doc-imyuupnw7022109.shtml","is_publish_highlight":false},{"id":"2337649277","title":"药明生物荣获国际制药工程协会2023年度\"最佳设施运营奖\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2337649277","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2337649277?lang=zh_CN&edition=full","pubTime":"2023-05-22 16:30","pubTimestamp":1684744200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4099914_ZH99914_1","is_publish_highlight":false},{"id":"2337616643","title":"港股反弹 恒指半日涨1.3% 药明生物(02269)升5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2337616643","media":"金吾资讯","top":-1,"share":"https://www.laohu8.com/m/news/2337616643?lang=zh_CN&edition=full","pubTime":"2023-05-22 12:18","pubTimestamp":1684729106,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052212184483cfc372&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052212184483cfc372&s=b","is_publish_highlight":false},{"id":"2337618221","title":"港股异动丨CRO概念股集体走强，药明生物涨6%，鲍威尔释放6月暂停加息信号","url":"https://stock-news.laohu8.com/highlight/detail?id=2337618221","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2337618221?lang=zh_CN&edition=full","pubTime":"2023-05-22 11:04","pubTimestamp":1684724695,"startTime":"0","endTime":"0","summary":"格隆汇5月22日丨CRO概念股今日集体走强，其中，药明生物涨6%，康龙化成涨近4%，药明康德和昭衍新药涨超2%。消息面上，鲍威尔释放6月暂停加息信号；另外，美联储卡什卡利近日表示，他可能在下次会议上支持维持利率不变。机构普遍认为，美联储加息或接近尾声，利好创新药估值提升，相关板块存在投资机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230522110501823b796d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230522110501823b796d&s=b","is_publish_highlight":false},{"id":"2337618675","title":"CRO概念股早盘普涨 药明生物涨超6%康龙化成涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2337618675","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2337618675?lang=zh_CN&edition=full","pubTime":"2023-05-22 11:04","pubTimestamp":1684724677,"startTime":"0","endTime":"0","summary":"CRO概念股早盘普涨，药明生物（02269）上涨6.41%，报44.85港元；康龙化成（03759）上涨4.02%，报32.35港元；药明康德（维权）（02359）上涨2.48%，报70.25港元；昭衍新药（06127）上涨1.86%，报30.05港元；凯莱英（06821）上涨0.67%，报104.70港元。\n\n炒股开户享福利，送投顾服务60天体验权，一对一指导服务！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/tob/2023-05-22/doc-imyuriak8372555.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2023-05-22/doc-imyuriak8372555.shtml","is_publish_highlight":false},{"id":"2337163690","title":"港股异动 | 药明生物(02269)涨超7%领涨CRO概念 机构预计CXO行业高景气度持续 板块仍具投资价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2337163690","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2337163690?lang=zh_CN&edition=full","pubTime":"2023-05-22 10:40","pubTimestamp":1684723205,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/933565.html","is_publish_highlight":false},{"id":"2336355308","title":"哀悼！2000亿巨头创始人去世，年仅57岁","url":"https://stock-news.laohu8.com/highlight/detail?id=2336355308","media":"中国基金报","top":-1,"share":"https://www.laohu8.com/m/news/2336355308?lang=zh_CN&edition=full","pubTime":"2023-05-17 09:41","pubTimestamp":1684287660,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"http://du.sov5.cn/t/!FJSZlpST05RZQ==","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://du.sov5.cn/t/!FJSZlpST05RZQ==","is_publish_highlight":false},{"id":"2336330645","title":"V观财报｜药明生物：联合创始人赵宁去世","url":"https://stock-news.laohu8.com/highlight/detail?id=2336330645","media":"中新经纬","top":-1,"share":"https://www.laohu8.com/m/news/2336330645?lang=zh_CN&edition=full","pubTime":"2023-05-17 08:28","pubTimestamp":1684283295,"startTime":"0","endTime":"0","summary":"药明生物在港交所公告，公司联合创始人、实际控制人之一、执行董事、高级副总裁赵宁，在与癌症勇敢抗争20年后，于2023年5月16日辞世。（中新经纬APP）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051708290182c978a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051708290182c978a9&s=b","is_publish_highlight":false},{"id":"2336337961","title":"药明生物(02269)：联合创始人赵宁辞世","url":"https://stock-news.laohu8.com/highlight/detail?id=2336337961","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2336337961?lang=zh_CN&edition=full","pubTime":"2023-05-17 08:23","pubTimestamp":1684282992,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明生物(02269)发布公告，公司联合创始人、非执行董事、公司薪酬委员会成员及公司环境、社会及管治委员会成员赵宁于2023年5月16日与世长辞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/931476.html","is_publish_highlight":false},{"id":"2336433757","title":"药明生物在港交所公告，联合创始人赵宁去世","url":"https://stock-news.laohu8.com/highlight/detail?id=2336433757","media":"虎嗅","top":-1,"share":"https://www.laohu8.com/m/news/2336433757?lang=zh_CN&edition=full","pubTime":"2023-05-17 08:19","pubTimestamp":1684282740,"startTime":"0","endTime":"0","summary":"药明生物在港交所公告，联合创始人赵宁去世。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051708195782c97845&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051708195782c97845&s=b","is_publish_highlight":false},{"id":"2335373804","title":"药明生物与德药企合作生产新冠药物 该药为同类首创抗C5a单抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2335373804","media":"经济观察网","top":-1,"share":"https://www.laohu8.com/m/news/2335373804?lang=zh_CN&edition=full","pubTime":"2023-05-16 21:16","pubTimestamp":1684242960,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051621223582c9633f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051621223582c9633f&s=b","is_publish_highlight":false},{"id":"2335799873","title":"药明生物与德国生物制药企业InflaRx达成生产合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2335799873","media":"证券时报","top":-1,"share":"https://www.laohu8.com/m/news/2335799873?lang=zh_CN&edition=full","pubTime":"2023-05-16 16:15","pubTimestamp":1684224933,"startTime":"0","endTime":"0","summary":"5月16日，药明生物宣布与InflaRx就新冠治疗药物Gohibic（vilobelimab）达成生产合作协议。FDA于2023年4月发布紧急使用授权（EUA），允许在接受有创机械通气或体外膜肺氧合后48小时内使用Gohibic治疗住院新冠重症成人患者。根据协议条款，药明生物将为同类首创的抗C5a单克隆抗体Gohibic提供cGMP/GMP制剂生产服务。InflaRx是一家总部位于德国耶拿的临床阶段生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051616033680657878&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051616033680657878&s=b","is_publish_highlight":false},{"id":"2334777317","title":"药明生物增长或大幅减速，分析师称其面临融资困难等风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2334777317","media":"新浪财经","top":-1,"share":"https://www.laohu8.com/m/news/2334777317?lang=zh_CN&edition=full","pubTime":"2023-05-11 18:11","pubTimestamp":1683799908,"startTime":"0","endTime":"0","summary":"我给予 药明生物 股票的评级为“卖出”。该公司的财务前景不佳，还面临着融资困难等重大风险。1增长速度将更为温和在3月底的2022财年财报发布会上，药明生物发布了其短期和中期增长指引。事实上，该公司管理层指引表明，该公司的增长将大幅减速。另外，有多种因素将对药明生物的未来利润率和盈利增长产生负面影响。4尽管存在重大风险因素，但药明生物的市盈率与增长比率仍高于1倍，预计该公司将呈现出更为温和的增长步伐。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230511182039844809ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230511182039844809ac&s=b","is_publish_highlight":false},{"id":"2334450637","title":"港股CXO概念异动拉升，药明康德涨超4%，恒生医疗ETF飘红","url":"https://stock-news.laohu8.com/highlight/detail?id=2334450637","media":"21世纪经济报道","top":-1,"share":"https://www.laohu8.com/m/news/2334450637?lang=zh_CN&edition=full","pubTime":"2023-05-11 11:28","pubTimestamp":1683775727,"startTime":"0","endTime":"0","summary":"南方财经5月11日电，港股CXO概念盘中异动拉升，药明康德涨超4%，昭衍新药、药明生物、凯莱英均涨超3%。消息面上，根据港交所披露文件显示，5月8日，The Capital Group Companies, Inc.在场内继续增持药明康德。增持后，The Capital Group所持股份占药明康德发行的H股股本的比例进一步上升至5.27%。重仓药明康德、药明生物的恒生医疗ETF一度涨超1%，随后震荡涨幅收窄，现涨0.37%，成交额超9亿元，换手率9.50%。上海证券表示，2023年二季度，维持医药生物行业“增持”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051111350684474fcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051111350684474fcf&s=b","is_publish_highlight":false},{"id":"2334386743","title":"【港股通】药明生物(02269)涨3.76% 此前获大摩看高至121港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2334386743","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2334386743?lang=zh_CN&edition=full","pubTime":"2023-05-11 10:58","pubTimestamp":1683773909,"startTime":"0","endTime":"0","summary":"药明生物(02269)盘中发力走高，最新报46.9港元，涨3.76%，成交额4.14亿港元。大摩此前发研报指，根据药明生物去年业绩表现和公司对今年至后年的收入年均复合增长率达30%的指引，更新对今年及往后收入预测。预计药明生物2022至2026年经调整净利润年均复合增长率为35%，而同期全球和内地生物制品需求增长为11%至15%。该行予其“增持”评级，以反映对该股高增长潜力和行业领先地位的看法，目标价由119港元升1.7%至121港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=f8ad32b36fd71ea916d37b172d80dfad","is_publish_highlight":false},{"id":"2334482787","title":"港股异动 | 康龙化成(03759)涨近5%领涨CRO概念 机构称宏微观压制估值因素均有显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2334482787","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2334482787?lang=zh_CN&edition=full","pubTime":"2023-05-11 10:48","pubTimestamp":1683773325,"startTime":"0","endTime":"0","summary":"浙商证券发布研报称，医药行业估值跌破历史低位。展望2023年，宏观和微观层面压制CXO板块估值的因素均有显著改善，市场情绪有望触底。该行表示，美联储加息强度和幅度边际望清晰，有望促使一级市场投融资和药企研发投入的趋势逐渐回暖，进一步驱动市场对CXO订单及业绩高增长可持续性的信心逐渐加强，估值进一步向上修复。看好2023H2全球生物医药投融资同比降幅大幅收窄甚至有所增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/928891.html","is_publish_highlight":false},{"id":"2334296522","title":"大摩：予药明生物增持评级 目标价升至121港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2334296522","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2334296522?lang=zh_CN&edition=full","pubTime":"2023-05-09 11:15","pubTimestamp":1683602100,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　大摩发布研究报告称，预计药明生物（02269）2022至2026年经调整净利润年均复合增长率为35%，而同期全球和内地生物制品需求增长为11%至15%。予“增持”评级，以反映对该股高增长潜力和行业领先地位的看法。目标价由119港元升至121港元。\n\n炒股开户享福利，送投顾服务60天体验权，一对一指导服务！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：史丽君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2023-05-09/doc-imytcwrc1738179.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2023-05-09/doc-imytcwrc1738179.shtml","is_publish_highlight":false},{"id":"2334293403","title":"大摩：予药明生物(02269)“增持”评级 目标价升至121港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2334293403","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2334293403?lang=zh_CN&edition=full","pubTime":"2023-05-09 10:36","pubTimestamp":1683599770,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，大摩发布研究报告称，预计药明生物(02269)2022至2026年经调整净利润年均复合增长率为35%，而同期全球和内地生物制品需求增长为11%至15%。予“增持”评级，以反映对该股高增长潜力和行业领先地位的看法。目标价由119港元升至121港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/927710.html","is_publish_highlight":false},{"id":"2333427503","title":"药明生物(02269.HK)：戴国良获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2333427503","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2333427503?lang=zh_CN&edition=full","pubTime":"2023-05-08 06:32","pubTimestamp":1683498729,"startTime":"0","endTime":"0","summary":"格隆汇5月8日丨药明生物(02269.HK)发布公告，戴国良已获委任为独立非执行董事、董事会审核委员会主席及提名委员会成员，均自2023年5月6日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230508063212820373d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230508063212820373d4&s=b","is_publish_highlight":false},{"id":"2332187893","title":"港股异动 | 维亚生物(01873)涨超6%领涨CRO概念 创新药行情逐渐回暖 CXO基本面有望迎来边际改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2332187893","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2332187893?lang=zh_CN&edition=full","pubTime":"2023-05-04 11:01","pubTimestamp":1683169289,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股多数走高，截至发稿，维亚生物(01873)涨6.29%，报1.52港元；昭衍新药(06127)涨5.15%，报31.65港元；金斯瑞生物科技(01548)涨4.9%，报20.35港元；药明生物(02269)涨3.07%，报47.05港元；。东吴证券近日研报指出，在环保趋严、医药生产制造向低成本地区转移、全球专利悬崖、集采、医保谈判、鼓励创新药研发等大背景下，CXO企业明显获益。该行认为，CXO板块估值处于历史低位，随着创新药行情逐渐回暖，新药研发需求增长，CXO基本面有望迎来边际改善，建议Q2积极关注CXO板块底部机会。推荐药明生物、金斯瑞生物科技等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/925613.html","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":-0.0724},{"period":"3month","weight":-0.1942},{"period":"6month","weight":-0.1005},{"period":"1year","weight":-0.1942},{"period":"ytd","weight":-0.2824}],"websiteUrl":"http://www.wuxibiologics.com","compareEarnings":[{"period":"1week","weight":-0.0497},{"period":"1month","weight":-0.0444},{"period":"3month","weight":-0.0631},{"period":"6month","weight":0.0668},{"period":"1year","weight":-0.0706},{"period":"ytd","weight":-0.0523}],"name":"药明生物","description":"药明生物技术有限公司是一家主要提供生物制剂发现、开发及生产服务的投资控股公司。该公司的技术平台包括WuXiBody TM双特异抗体技术平台及抗体偶联药物（ADC）技术平台等。其引入多个新项目至研发管线。该公司有疫苗生产基地，为客户生产疫苗以供应全球市场。该公司于中国市场及北美，欧洲和其他海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.092904},{"month":2,"riseRate":0.5,"avgChangeRate":-0.028739},{"month":3,"riseRate":0.666667,"avgChangeRate":0.034212},{"month":4,"riseRate":0.5,"avgChangeRate":0.03188},{"month":5,"riseRate":0.5,"avgChangeRate":0.028441},{"month":6,"riseRate":0.6,"avgChangeRate":0.103025},{"month":7,"riseRate":0.666667,"avgChangeRate":0.05086},{"month":8,"riseRate":0.5,"avgChangeRate":0.044354},{"month":9,"riseRate":0.5,"avgChangeRate":-0.053499},{"month":10,"riseRate":0.5,"avgChangeRate":-0.030731},{"month":11,"riseRate":0.666667,"avgChangeRate":0.092738},{"month":12,"riseRate":0.5,"avgChangeRate":0.037056}],"exchange":"SEHK","nameEN":"WUXI BIO","compareStock":{"symbol":"HSI","name":"恒生指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.13.0","shortVersion":"4.13.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物,02269,药明生物股票,药明生物股票老虎,药明生物股票老虎国际,药明生物行情,药明生物股票行情,药明生物股价,药明生物股市,药明生物股票价格,药明生物股票交易,药明生物股票购买,药明生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}